Based on Fortune Business Insights’ report, the treatment- resistant depression treatment market share sector attained a worth of USD 1.71 billion in 2022. Forecasts indicate a promising path ahead, foreseeing a Compound Annual Growth Rate (CAGR) of 11% from 2022 to 2030. This trajectory will culminate in a noteworthy achievement of USD 4.06 Billion by 2030, highlighting considerable opportunities within […]


